Thema
Letter
Comment
49
Research Support, Non-U.S. Gov't
27
Case Reports
23
coronavirus
12
COVID-19
11
Angiotensin-Converting Enzyme 2
6
EC 3.4.17.23
6
Immunoglobulin G
6
Antibodies, Monoclonal, Humanized
5
Antibodies, Viral
5
Antiviral Agents
5
I031V2H011
5
Immunoglobulin M
5
tocilizumab
5
RNA, Viral
4
SARS-CoV-2
4
Meta-Analysis
3
infection
3
virus classification
3
2494G1JF75
2
9007-41-4
2
ACE2
2
Adamantane
2
Anti-HIV Agents
2
C-Reactive Protein
2
HIV
2
Interleukin-6
2
Lopinavir
2
O3J8G9O825
2
PJY633525U
2
Ritonavir
2
SARS coronavirus
2
Spike Glycoprotein, Coronavirus
2
Viral Nonstructural Proteins
2
coronavirus < virus classification
2
epidemiology
2
immune responses
2
pandemics
2
pandemics < epidemiology
2
public policy
2
2019-nCoV
1
4QWG6N8QKH
1
66H7ZZK23N
1
82115-62-6
1
9100L32L2N
1
ACE2 protein, human
1
Adjuvants, Pharmaceutic
1
Amantadine
1
Angiotensin II Type 1 Receptor Blockers
1
mehr ...